|
Vazyme Biotech Co
mouse cd8 t cell isolation kit ![]() Mouse Cd8 T Cell Isolation Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/Mouse+CD8%2B+T+Cell+Isolation+Kit/pmc13752232-360-11-19 Average 94 stars, based on 1 article reviews
mouse cd8 t cell isolation kit - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Novartis
car t-cells ![]() Car T Cells, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/car+t+cells/nct04283006-3-9-9 Average 90 stars, based on 1 article reviews
car t-cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
clinimacs prodigy automated t cell transduction tct process ![]() Clinimacs Prodigy Automated T Cell Transduction Tct Process, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/CliniMACS+Prodigy/nct05779930-0-53-52 Average 98 stars, based on 1 article reviews
clinimacs prodigy automated t cell transduction tct process - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Eve Technologies Corporation
human high sensitivity t-cell discovery array 14-plex (hdhstc14 ![]() Human High Sensitivity T Cell Discovery Array 14 Plex (Hdhstc14, supplied by Eve Technologies Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/human+high+sensitivity+t+cell+discovery+array+14+plex++hdhstc14/nct05806385-145-18-10 Average 90 stars, based on 1 article reviews
human high sensitivity t-cell discovery array 14-plex (hdhstc14 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
cd8 t cells ![]() Cd8 T Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/Bafilomycin+A1/pmc13755765-270-13-26 Average 99 stars, based on 1 article reviews
cd8 t cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human embryonic kidney 293 t cells ![]() Human Embryonic Kidney 293 T Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/293T/pmc13753392-41-0-12 Average 99 stars, based on 1 article reviews
human embryonic kidney 293 t cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Bio X Cell
cd8 t cell depleting antibody ![]() Cd8 T Cell Depleting Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/InVivoMAb+anti-mouse+CD8%CE%B2/pm42962666-766-14-20 Average 96 stars, based on 1 article reviews
cd8 t cell depleting antibody - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Bio X Cell
cd4 t cell depleting antibody ![]() Cd4 T Cell Depleting Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/InVivoMAb+anti-mouse+CD4/pm42962666-766-21-26 Average 97 stars, based on 1 article reviews
cd4 t cell depleting antibody - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
ATCC
human embryonic kidney cell t hek293t ![]() Human Embryonic Kidney Cell T Hek293t, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/293T/bio_rxiv__64898__2026__11__05__764603-182-0-9 Average 99 stars, based on 1 article reviews
human embryonic kidney cell t hek293t - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Biotium
membrane specific dye membrite fix cell surface staining kits ![]() Membrane Specific Dye Membrite Fix Cell Surface Staining Kits, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/t+cells/MemBrite+Fix+405%2F430+Cell+Surface+Staining+Kit/bio_rxiv__64898__2026__11__03__764065-273-19-28 Average 93 stars, based on 1 article reviews
membrane specific dye membrite fix cell surface staining kits - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Journal: Exploration
Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation
doi: 10.1002/exp2.70249
Figure Lengend Snippet: Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated CD8 + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the
Techniques: CCK-8 Assay, Activation Assay, Expressing, Quantitative RT-PCR, Morphology, Dynamic Light Scattering Assay, Transmission Assay, Electron Microscopy, Elemental Analysis, Confocal, Imaging, Labeling, Staining, Fluorescence, Incubation
Journal: Exploration
Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation
doi: 10.1002/exp2.70249
Figure Lengend Snippet: NAD + supplementation protects MSCs from death and boosts their anti‐inflammatory potential in vivo. (A) The reduction in cell viability of MSCs after IT treatment can be reversed by the addition of 25 µM NANP ( n = 3). (B) TMRE staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, presented as cytofluorometric dot plots and statistical analysis ( n = 3). (C) Annexin V/DAPI dual staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, shown as cytofluorometric dot plots and statistical analysis ( n = 3). (D) MSCs treated with 25 µM NANP, IT, or their combination for 48 h, the expression of apoptosis executors (CASP3 and cleaved CASP3), and necroptosis executors (RIPK3 and p‐RIPK3) was measured by semiquantitative WB. (E) 25 µM NANP restores the ability of 5‐days IT‐treated MSCs to inhibit anti‐CD3/CD28‐stimulated CD8 + T cell proliferation. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (F) Schematic diagram showing the preparation of NAD + ‐loaded MSCs. (G) Schematic diagram showing the MSCs‐treated IBD model. (H) Body weight measurements of IBD mice were administered either MSCs or NAD + ‐loaded MSCs ( n = 5). (I) Colon length of IBD mice and quantitative analysis compared between DSS, MSCs, and NAD + ‐loaded MSCs ( n = 5). (J) Representative H&E‐stained colon sections and histological scores of IBD mice administered by MSCs or NAD + ‐loaded MSCs ( n = 5). (K) IVIS imaging of colon tissues. The mice were euthanized at 48 h after administration, and the colon was immediately removed for imaging with an IVIS Lumina Series (left panel). Average radiant efficiency was compared between MSCs and NAD + ‐loaded MSCs (right panel) ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the
Techniques: In Vivo, Staining, Analysis, Expressing, Imaging
Journal: Exploration
Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation
doi: 10.1002/exp2.70249
Figure Lengend Snippet: NANP‐primed MSCs reprogram colitic immunity by restraining inflammatory trafficking. (A) Proportion of CD45 + immune cells in the colon tissues of IBD mice, 6 days post‐MSCs therapy ( n = 6). (B) Distribution of major colonic immune cell subsets, quantified by flow cytometry ( n = 6). (C) Gating strategy for identifying F4/80 + CD206 + macrophages, and statistical analyses are shown ( n = 6). (D) Immunofluorescence imaging of colon sections depicting F4/80 + CD206 + cells (green: F4/80, red: CD206, and blue: DAPI) in MSCs‐treated IBD mice, and statistical analyses were shown ( n = 6). (E, F) RNA sequencing analysis identified differential gene expression in MSCs treated with PBS versus NANP, presented as a volcano plot (E) and Gene Ontology enrichment analysis (F) of significantly regulated genes. (G) Heatmap displaying the differential expression of genes involved in regulating cell migration, comparing PBS and NANP treatment. (H) Heatmap view of differential expression gene involved in negative regulation of apoptosis between MSCs and NANP‐treated MSCs. (I) The combination of 25 µM NANP with IT did not enhance anti‐inflammatory cytokine expression compared to IT alone in MSCs ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the
Techniques: Immune Cell, Flow Cytometry, Immunofluorescence, Imaging, RNA Sequencing, Analysis, Gene Expression, Quantitative Proteomics, Migration, Expressing, RNA Expression
Journal: Advanced Science
Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy
doi: 10.1002/advs.78385
Figure Lengend Snippet: BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.
Article Snippet: To assess autophagic flux, BMDMs transfected with siNC or siTREM2 were co‐cultured with CD8 + T cells for 48 h.
Techniques: Western Blot, Expressing, Flow Cytometry, Cell Culture, Membrane, Fluorescence, Co-culture Assay, Transfection, Knockdown, Two Tailed Test
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A) Schematic of the CRISPR screen workflow. B-C) Volcano plots of (B) the kinome screen results showing the log 2 FC vs −log 10 p-adjusted value (FDR<0.05) enrichment score per gene or (C) the genome-wide screen results showing the log 2 FC vs −log 10 p-value (p<0.08) enrichment score per gene that increased MeCP2 (green) or decreased MeCP2 (red) expression. D-E) Validation of top screen hits on endogenous MeCP2 levels relative to loading control (GAPDH) in HEK293T cells using independent sgRNAs or dual guide RNA vectors (dgRNAs). Combined bar plot showing target gene knockout (KO) efficiency (left) and corresponding changes to MeCP2 levels (right) as measured by western blot quantification compared to respective non-targeting (NT) control samples, stabilizers (red) and destabilizers (green). Data presented as mean ± SEM, **p<0.005, ***p<0.0005, ****p<0.0001 using a one-way ANOVA with post-hoc Dunnett’s multiple comparisons between gene-targeting sgRNAs or dgRNAs to respective NT samples. F-I) Quantification of endogenous MeCP2 levels relative to loading controls (GAPDH or VCL) in HEK293T cells after 72hr incubation with (F) BRD4 inhibitor JQ1 at 10uM, (G) CDK9 inhibitor LDC000067 at 10uM, (H) MTOR inhibitor Rapamycin at 1 uM, or (I) agonist of AMPK pathway Metformin at 0.5uM. Data presented as mean ± SEM, p-values determined using a Student’s t-test.
Article Snippet:
Techniques: CRISPR, Genome Wide, Expressing, Biomarker Discovery, Control, Gene Knockout, Western Blot, Gene Targeting, Incubation, FACS, Significance Assay
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A) Prioritization of screen hits filtered by overlapping kinome-genome, human and mouse brain expression, MeCP2 PPIs , , druggability, and disease association (OMIM#). B) Venn diagram of overlapping clinical phenotypes of Rett syndrome (RTT), Okur Chung Neurodevelopmental Syndrome (OCNDS), and MECP2 duplication syndrome (MDS). C) Western blot and quantification of CSNK2A1 and MeCP2 total protein levels relative to loading control (VCL) in HEK293T-Cas9 cells infected with either dgCK2A1 or dgNT KO. D) Western blot and quantification of CSNK2A1 and MeCP2 levels relative to loading control (VCL) from HEK-293Ts overexpressing either YFP or CSNK2A1. Data presented as mean ± SEM, p-values calculated using a student’s t-test for C-D. E) IP western blot for FLAG or IgG in CSNK2A1 KO or WT (NT) HEK293Ts overexpressing Flag-MeCP2, probing for FLAG and CSNK2A1 in input and IP samples. F) IP western blot of endogenous MeCP2 or IgG control from mouse brain regions: cortex (CTX), hippocampus (HIP), or cerebellum (CB) in WT or Mecp2 -/y (MeCP2 null) mice. G) IP of MeCP2 at embryonic (E18) and post-natal timepoints (P5, P7, P28, and P63) and quantification of MeCP2-CSNK2A1 interaction over development (representative western blot from replicate 1). H) Schematic of intracerebroventricular (ICV) injection protocol using an AAV8 miR30-YFP 4-shRNA virus targeting Csnk2a1 or NT into P0 WT pups. I) 20X immunofluorescent (IF) image of the viral spread post-injection of an AAV-YFP-shNT injection at 4 weeks and colocalization with MeCP2 (gray) and neuron marker NeuN (magenta). J) Western blot and quantification of combined cortical/hippocampal protein samples at 8 weeks post-injection measuring levels of (K) CSNK2A1 and (L) MeCP2 relative to loading control (GAPDH). Data presented as mean ± SEM, p-values calculated using a student’s t-test between shNT and shCSNK2A1 samples.
Article Snippet:
Techniques: Expressing, Western Blot, Control, Infection, Injection, shRNA, Virus, Marker
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A-B) qRT-PCR of (A) CSNK2A1 and (B) MECP2 relative to ACTIN (housekeeping gene) in HEK293T-Cas9 cells infected with either dgCK2A1 (KO) or dgNT (control). C-D) Replicates (2 and 3) of IP for MeCP2 at embryonic (E18) and post-natal timepoints (P5, P7, P28, and P63) blotting for (C) CSNK2A1 or (D) MeCP2. (E-G) Dual in situ probes for Mecp2 and Csnk2a1 and stained with DAPI in a representative adult sagittal brain section at 10X (E) or 40X oil (F-G). OB= olfactory bulb, CTX= cortex, STR= striatum, HIP= hippocampus, CB= Cerebellum. Cornu Ammonis (CA) 1-3 and the dentate gyrus (DG) are subregions of the hippocampus. Scale bar= 1mm (E), 500um (F-G). H-I) qRT-PCR from AAV- shCsnk2a1 or shNT P0 mouse ICV injections quantifying (H) Csnk2a1 and (I) Mecp2 relative to Actin . Data presented as mean ± SEM, p-values using a Student’s t-test.
Article Snippet:
Techniques: Quantitative RT-PCR, Infection, Control, In Situ, Staining, Olfactory
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A) Western blot and quantification of MeCP2 protein levels relative to loading control (GAPDH) in HEK293T cells incubated with CSNK2A1 inhibitor TBB or DMSO vehicle control for 72hrs at 1uM or 10uM. B) Structure of CDD-2021 compound and (C) western blot and quantification of MeCP2 protein levels (left) relative to loading control (VCL) or MECP2 RNA levels relative to ACTIN (housekeeping gene) via qRT-PCR (right) in HEK293T cells incubated with CDD- 2021 at nM doses for 72hrs. Data presented as mean ± SEM, p-values determined using a one-way ANOVA with post-hoc Dunnett’s multiple comparisons. D) Schematic of experimental design. Western blots and quantification of MeCP2 stability relative to loading control (GAPDH) using the DOX-inducible experimental design to overexpress MeCP2-e2 in the presence of TBB (10uM), CDD2021 (10uM), or DMSO (control). Data presented as mean ± SEM, p-values determined using a two-way ANOVA with Tukey’s post-hoc multiple comparisons **P<0.005. E) Timeline of experimental design. Western blots and quantification of endogenous levels of MeCP2 relative to loading control (GAPDH) following treatment with DMSO or CDD-2021 (250nM) for 72hrs followed by incubation with either MLN-4924 (0.3uM, Nedd8-activating enzyme inhibitor), MG-132 (10uM, proteasome inhibitor), or DMSO (vehicle) 8hrs prior to harvest. NEDD8 blot shows MLN-4924 effectively inhibits neddylation. Data presented as mean ± SEM, p-values determined using a one-way ANOVA with post-hoc Sidak’s multiple comparisons.
Article Snippet:
Techniques: Western Blot, Control, Incubation, Quantitative RT-PCR, Stability
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A) Western blot and quantification of MeCP2 levels relative to loading control (GAPDH) in HEK293T cells incubated with CX-4945 at low doses for 72hrs. Data presented as mean ± SEM, p-values determined using a one-way ANOVA with post-hoc Dunnett’s multiple comparisons. B-D) Quantification of ubiquitination assay performed in HEK293T cells. Briefly, HA-Ubiquitin and FLAG-MECP2 were transfected into cells +/−CDD2021 (1uM) for 48hr followed by an 8hr incubation with (B) DMSO (no inhibitor), (C) proteasome inhibitor (MG-132, 10uM), or (D) lysosome inhibitor (CQ, 40um) before harvest. IP of FLAG in each sample was followed by western blot and quantification of HA (Ubiquitinated MeCP2)/FLAG (total MeCP2). Data presented as mean ± SEM, p-values determined using a Student’s t-test.
Article Snippet:
Techniques: Western Blot, Control, Incubation, Ubiquitin Proteomics, Transfection
Journal: bioRxiv
Article Title: Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2 -related disorders
doi: 10.64898/2026.11.05.764603
Figure Lengend Snippet: A) Schematic of the IP/MS experiment and coverage (red line) with location of phosphorylated serine residues in distinct protein domains of MeCP2 (NTD= N-terminal domain, MBD= methyl CpG binding domain, ID= intervening domain, TRD= transcriptional repressor domain, CTD= C-terminal domain). B) Graph showing normalized quantification of phosphorylated peptides over total peptides detected in sgNT and sgCSNK2A1 samples (N=2/condition, no statistical comparisons). C-D) Schematic of pInducer DOX-inducible experiment with Flag-MECP2 (WT) vs Flag-MECP2 serine to alanine mutations (S80A, S229A, or S326A) with western blots and quantification of MeCP2 relative to loading control (GAPDH) across each timepoint normalized to 0hr (continuous DOX) timepoint. Data presented as mean ± SEM, p-values determined using a two-way ANOVA with Tukey’s post-hoc multiple comparisons.
Article Snippet:
Techniques: Protein-Protein interactions, Binding Assay, Western Blot, Control, Liquid Chromatography with Mass Spectroscopy, Tandem Mass Spectroscopy
Journal: bioRxiv
Article Title: Ferroptosis of selective progenitor cell types during embryogenesis ensures proper organ morphogenesis
doi: 10.64898/2026.11.03.764065
Figure Lengend Snippet: TUNEL positivity in TfR1 and 4-HNE double positive cells in E14.5 lungs ( a ) and E18.5 kidney ( b ). Triple TfR1, 4-HNE and TUNEL positive cells in wild-type (WT), GPX4 cKO (GPX4f/f;Nkx2.1-Cre) for lungs and GPX4 cKO (GPX4f/f:Flk1-Cre) for kidneys, and GPX4 Tg. Triple positive cells are indicated by white arrows. Representative images of E14.5 lung (c) and E18.5 kidney (d) in cell membrane dye (MemBrite) and nuclear dye (Sytox) perfusion staining. Double positive cells are indicated with white arrows. Lung or kidney of 3 embryos from three different litters ( n = 3) were analyzed, minimum 3 sections per embryo were stained. Electron microscopic images for E14.5 lung distal epithelium (e) and E18.5 kidney glomerulus (f). The presence of a dead cell reminiscence (e-1), condensed nucleus (N), swollen lytic mitochondria (M) and the damaged membrane indicated by black arrowheads (e-1, e-2). A cell with condensed and shrinked mitochondria with abnormal cristae, compromised membrane indicated by white arrow (e-2). Shrinked lytic mitochondria, in a dead cell (e-3), condensed nucleus (N), lytic mitochondria (M) and stressed vacuole (V) and the damaged membrane indicated by black arrowhead. Mitochondria in the apparently healthy cell in the lung (e-4). In E18.5 glomerulus, a dying cell (f-1), cells with mitochondrial defects (f-2, f-3) and an apparently healthy cell (f-4) are indicated. Presence of the blood cells are indicated by red arrowheads, and M: mitochondria and N: Nucleus. In the dying cell (f-1) condensed nucleus (N), swollen mitochondria (M) and stressed vacuole (V) and the compromised membrane are indicated by black arrowhead. Mitochondria defective cells showed both shrinked (f-2) and swollen mitochondrial morphology (f-3). Embryos from three different litters ( n = 3) were analyzed.
Article Snippet: Direct detection of the live and dead cells in the embryonic lung and kidney tissue was performed by using
Techniques: TUNEL Assay, Membrane, Staining, Morphology
Journal: bioRxiv
Article Title: Ferroptosis of selective progenitor cell types during embryogenesis ensures proper organ morphogenesis
doi: 10.64898/2026.11.03.764065
Figure Lengend Snippet: ( a ) Representative immunostaining of triple TfR1, 4-HNE and TUNEL staining in experimental positive and negative control for ferroptosis and TUNEL staining. The top panel stands for lungs and the lower panel for kidney. Experimental positive control for ferroptosis was the treatment of ERSTN (Erastin) and the negative control was the treatment of Fer-1 (Ferrostatin-1). TUNEL positive control was Staurosporine treatment. ( b ) Cell membrane dye MemBrite and nuclear dye SytoxRed perfusion staining of experimental positive (E12.5 lung treated with ERSTN) and Negative (E14.5 lung treated with Fer-1) control for lung (upper panel) and kidney (E15.5 kidney treated with ERSTN and E18.5 kidney treated with Fer-1) (lower panel). ( c ) Apreo SEM micrograph of E14.5 lung from GPX4 Tg and ( d ) E18.5 kidney glomerulus from GPX4 Tg (upper panel) and GPX4 cKO(GPx4ff:flk1 Cre) (lower panel). Mitochondria from specified region where ferroptotic cells are identified are focused. ( e ) Representative transmission electron microscopy images for flow-through and TfR1 pulldown cells from E14.5 lung and ( f ) E18.5 Kidney. Condensed nucleus (N), Shrink or swollen mitochondria (M) are indicated. Embryos from three different litters ( n = 3) were analyzed.
Article Snippet: Direct detection of the live and dead cells in the embryonic lung and kidney tissue was performed by using
Techniques: Immunostaining, TUNEL Assay, Staining, Negative Control, Positive Control, Membrane, Control, Transmission Assay, Electron Microscopy